6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA

Clinical trial NCT00360243 · COMPLETED

Trial details

NCT number: NCT00360243
Sponsor: Sprout Pharmaceuticals, Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Sexual Dysfunctions, Psychological

Start date: 2006-07-01
Primary completion: 2008-04-01
Enrollment: 1385

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.